Prospective Clinical Assessment Study in Children with Achondroplasia: The PROPEL Trial
Primary Objective
To collect baseline height velocity measurements of children with achondroplasia (ACH) being considered for future enrollment in interventional studies sponsored by QED Therapeutics
Details
Age
Child
Eligibility
Aged 2.5 <17years, diagnosis of ACH, ambulatory and able to stand without assistance, and participant, parent, or legally authorized representative willing and able to comply with study visits and procedures.
Locations
Childrens Hospital Colorado
Principal Investigator
Klane White
Study ID
Protocol Number: 23-0416
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers